N
Glam Journal

What company owns Aurobindo?

Author

Ava White

Updated on March 14, 2026

What company owns Aurobindo?

The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer….Aurobindo Pharma.

TypePublic
IndustryPharmaceuticals
Founded1986
FoundersV. Ramprasad Reddy K. Nityananda Reddy
HeadquartersHyderabad, Telangana, India

What does Aurobindo Pharma do?

The company makes use of in-house research and development (R&D) for rapid filing of patents, drug master files (DMFs), abbreviated new drug applications (ANDAs) and formulation dossiers across the world. It is among the largest filers of DMFs and ANDAs from India.

What drugs does Aurobindo make?

Product Catalog

  • Abacavir Sulfate & Lamivudine Tablets.
  • Abacavir Tablets.
  • Acetaminophen & Codeine Tablets, USP C-III.
  • Afirmelle™ (Levonorgestrel and Ethinyl Estradiol Tablets)
  • Alendronate Sodium Tablets, USP.
  • Alprazolam ER Tablets C-IV.
  • Alprazolam Tablets C-IV.
  • Alprazolam Tabs.

Is Aurobindo a good drug company?

Aurobindo is the fastest growing Top 5 Generic Pharma Company in TRx Volume. * *Among top 5 generic pharma companies ranked by TRx volume in 2017; in average Trx growth from 2010 to 2017.

What kind of birth control is Aurobindo?

Aurobindo Pharma Limited has launched Mili™ and Tri-Mili™ lines of oral contraceptive tablets. Aurobindo’s Mili™ and Tri-Mili™ are an AB-rated generic equivalent to the reference listed drugs Ortho Cyclen® and Ortho Tri-Cyclen®. Mili™ is an estrogen/progestin COC, indicated for use by women to prevent pregnancy.

What is Aurobindo generic for?

Oxycodone hydrochloride oral
Aurobindo’s product is the generic of Genus Lifesciences’ Oxycodone hydrochloride oral solution, 5 mg/5 mL (1 mg/mL) and 100 mg/5 mL (20 mg/mL). Oxycodone hydrochloride oral solution has a market value of about $33 million for the 12 months ending December 2019, according to IQVIA.

Are Aurobindo drugs safe?

India’s Aurobindo Pharma has been one of the culprits found manufacturing the high blood pressure medicine valsartan with high levels of impurities that carry a risk of cancer. Now the FDA has savaged it in a warning letter for missteps that paved the pathway to the mess.

Where are Aurobindo drugs made?

Company Description: Aurobindo Pharma U.S.A., Inc. is located in East Windsor, NJ, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry.

Where is Aurobindo based?

East Windsor, NJ
Company Description: Aurobindo Pharma U.S.A., Inc. is located in East Windsor, NJ, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry.

What type of birth control is Aurobindo?

Does Aurobindo prevent pregnancy?

Is Aurobindo a combination pill?

This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: norethindrone (a progestin) and ethinyl estradiol (an estrogen). It works mainly by preventing the release of an egg (ovulation) during your menstrual cycle.

Is Aurobindo Pharma a private or public company?

Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. Aurobindo Pharma also has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.

What is Aurobindo’s Unit-4?

Aurobindo Pharma announced that it is transferring Unit-4 (injectable and ophthalmic) to its wholly-owned Eugia subsidiary. Transferring Unit-4 (injectable and ophthalmic) to its wholly-owned Eugia subsidiary.

How many countries does Aurobindo export to?

Aurobindo exports to over 125 countries with more than 70% of its revenues derived out of international operations. In 2014, Aurobindo purchased the generic operations of Actavis in 7 Western European countries for $41 million.

How Aurobindo will benefit from injectable generic business under one roof?

Injectable generic business under one roof will help in greater operational efficiencies As per analysts, Aurobindo has ~$400mn of generic injectable and ~$95mn of onco branded injectable that together accounts for ~14% of the company’s topline.